A detailed history of Quadrant Capital Group LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 334 shares of LNTH stock, worth $27,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
334
Previous 122 173.77%
Holding current value
$27,000
Previous $9,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$77.7 - $123.62 $16,472 - $26,207
212 Added 173.77%
334 $36,000
Q2 2024

Aug 12, 2024

BUY
$58.87 - $83.05 $3,649 - $5,149
62 Added 103.33%
122 $9,000
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $22,470 - $30,034
-440 Reduced 88.0%
60 $3,000
Q4 2023

Feb 08, 2024

SELL
$55.6 - $77.89 $12,843 - $17,992
-231 Reduced 31.6%
500 $31,000
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $14,163 - $21,326
235 Added 47.38%
731 $50,000
Q2 2023

Aug 09, 2023

BUY
$82.41 - $99.65 $21,921 - $26,506
266 Added 115.65%
496 $41,000
Q1 2023

May 11, 2023

SELL
$47.76 - $82.86 $1,098 - $1,905
-23 Reduced 9.09%
230 $18,000
Q4 2022

Feb 10, 2023

SELL
$48.76 - $77.67 $59,487 - $94,757
-1,220 Reduced 82.82%
253 $12,000
Q3 2022

Nov 10, 2022

BUY
$61.42 - $86.29 $73,581 - $103,375
1,198 Added 435.64%
1,473 $104,000
Q2 2022

Aug 09, 2022

BUY
$55.54 - $72.65 $12,996 - $17,000
234 Added 570.73%
275 $18,000
Q1 2022

May 06, 2022

BUY
$24.28 - $56.64 $995 - $2,322
41 New
41 $2,000
Q4 2021

Feb 01, 2022

SELL
$22.54 - $30.44 $112 - $152
-5 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$24.23 - $28.59 $121 - $142
5 New
5 $0
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $344 - $477
-32 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$11.98 - $16.34 $1,233 - $1,683
-103 Reduced 76.3%
32 $0
Q2 2020

Aug 13, 2020

BUY
$10.34 - $15.51 $1,065 - $1,597
103 Added 321.88%
135 $2,000
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $291 - $641
32 New
32 $0

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.